Hasandalan, Krystal .

HRN: 23-83-73  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2024
AMPICILLIN 500MG (VIAL)
10/30/2024
11/05/2024
IV
400mg
Q6
Pcap
Waiting Final Action 
10/30/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/30/2024
11/05/2024
IV
120
OD
Pcap
Waiting Final Action 
10/31/2024
CEFUROXIME 1.5GM (VIAL)
10/31/2024
11/06/2024
IV
270mg
Q8
PCAP C
Waiting Final Action 
10/31/2024
CEFTRIAXONE 1G (VIAL)
10/31/2024
11/06/2024
IV DRIP
360mg
Q12
Typhoid Fever
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: